5th International Congress on Psycpharmacology

October 30, 2013
Wednesday
October 31, 2013
Thursday
November 1, 2013
Friday
November 2, 2013
Saturday
November 3, 2013
Sunday

October 31, 2013 - Thursday

07:30-09:00 Course-4
Bipolar Disorders in Child and Adolescents and Management of their Comorbidities

Aynur Akay (Turkey) (Turkish)
Neslihan Emiroglu (Turkey) (Turkish)
 Course-5
DSM 5 Orientation and Training

Dost Ongur (USA) (English)
 Course-6:
Mastery in Pharmacotherapy Plus Psychotherapy Combinations

Hakan Turkcapar (Turkey) (Turkish)
 Course-7:
Experimental Animal Models of Schizophrenia

Osman Metin Ipcioglu (Turkey) (Turkish)
Huseyin Gunay (Turkey) (Turkish)
09:00-10:30

HALL A
PLENARY LECTURE:
Symptoms or Poor Coping Strategies? Clarifying the Confusion with Success Strategies for Late-Diagnosis Adults with ADHD and Their Loved Ones
Gina Pera (USA)

Moderator:
M Akif Ersoy (Turkey)

HALL B
Symposium-4
Psychopharmacological Treatment Difficulties and Coping Methods in Children and Adolescents - I

Dicussant Moderators:
Bengi Semerci (Turkey) - John T. Walkup (USA)

Epigenetics and psychiatry
Ozlem Ozcan (Turkey)

Alternative approaches to treatment resistance in children and adolescents with obsessive-compulsive disorder
Kagan Gurkan (Turkey)

Difference of approaches for treatment of social anxiety disorder in adolescents
Sabri Herguner (Turkey)

Is it necessary to use antidepressants in children and adolescents with depressive disorders?
Omer Faruk Akca (Turkey)

Pharmacokinetics, pharmacodynamics, and pharmacogenetics approach in child and adolescent psychiatry in Turkey and the world
Caner Mutlu (Turkey)

HALL C
Joint Symposium:-3: TAP - Russian Scientific Society of Pharmacologists
Neuroprotection: Myth or fact?


Discussant Moderators:
Elena Valdman (Russia) -
Rustem Askin (Turkey)

Neuroprotection through GABA receptors
Huseyin Gunay (Turkey)

Neuroprotective properties of the sigma-1 ligand afobazol
Sergey Seredenin (Russia)

Novel antiparkinsonian and neuroprotective drug hemantane
Elena Valdman (Russia)

Importance of neuroprotection in clinical practice
Umit Basar Semiz (Turkey)

10:30-11:00 COFFEE BREAK
11:00-12:00

Previous 15 years, today and the future of schizophrenia treatment and atypical antipsychotics.

Prof. Dr. Nesrin Dilbaz: Future Aspects in treatment of schizophrenia and atypical antipsychotics
Prof. Dr. Baybars Veznedaroğlu: What we have in treatment of schizophrenia and atypical antipsychotics.
Prof. Dr. Oğuz Karamustafalıoğlu: Last 15 years in treatment of schizophrenia and atypical Antipsychotics.

12:00-13:00 LUNCH
13:00-14:30

HALL A
Joint Symposium-4: TAP - Czech Neuropsychopharmacological Society (CNPS)
Actual Issues in Schizophrenia Treatment

Discussant Moderators:
Pavel Mohr (Czech Republic) -
Oguz Karamustafalioglu (Turkey)

Cardiometabolic risk in patients with schizophrenia: impact of medication and monitoring
Jiri Masopust (Czech Republic)

Functional impairment and antipsychotic treatment of schizophrenia patients
Pavel Mohr (Czech Republic)

Can we eliminate relapses in schizophrenia?
Filip Spaniel (Czech Republic)

Neuroplasticity-based brain stimulation and psychopharmacology in neuropsychiatry
Martin Anders (Czech Republic)

Coping with adherence problems in longterm psychiatric treatments
Hakan Turkcapar (Turkey)

Smoking and beyond in psychiatric patients
Koksal Alptekin (Turkey)

HALL B
Symposium-5:
Psychopharmacological Treatment Difficulties and Coping Methods in Children and Adolescents-II

Discussant Moderators:
Tumer Turkbay (Turkey) -
Mucahit Ozturk (Turkey)

First-episode psychotic disorders in children and adolescents
Pinar Oner (Turkey)

Current approaches for treatment of tic disorders in children and adolescents
Canan Tanidir (Turkey)

Emergency situations in child and adolescent psychiatry and its management
Ayse Kilincaslan (Turkey)

The importance of pharmacogenetics in child and adolescent psychiatry
Nukhet Isiten (Turkey)

HALL C
Joint Symposium-5 : TAP - ISNP
Treatment of Bipolar Disorder: From Molecular Hypotheses to Clinical Reality

Discussant Moderators:
Konstantinos N Fountoulakis (Greece) ,
Numan Konuk (Turkey)

Targeting specific receptors and neurotransmitter systems in the treatment of bipolar disorder
Konstantinos N Fountoulakis (Greece)

PKC & GSK3B pathways as potential new treatment targets for bipolar disorder
Aysegul Yildiz (Turkey)

Evidence based treatment and refined treatment guidelines for bipolar disorder
Matina Magiria (Greece)

Pharmacoepidemiology of bipolar disorder: a systematic review of the literature
Dimos Dimelis (Greece)

Treatment resistance and its management strategies in bipolar disorders
Erhan Kurt (Turkey)

14:30-15:00 COFFEE BREAK
15:00-16:00

A new perspective in the treatment of negative symptoms: Glutamate Theory and Glycine Reuptake Inhibition
Moderator: Mesut Çetin
Speakers: Nesrin Dilbaz
Ali Saffet Gönül

16:00-17:00

Poster Session

Moderators
Selim Kılıç
Alican Dalkılıç
Murad Atmaca
Cengiz Başoğlu
Bengi Semerci

16:00-16:30

COFFEE BREAK

16:30-18:30

HALL A
Symposium-6:
Eating Disorders: From nosology to treatment - An update

Discussant Moderators:
Alican Dalkilic (USA) - Atila Erol (Turkey)

Eating disorders in DSM-5 and the rationales for the changes compared to DSM-IV and epidemiology of eating disorders
H. Hoek (Netherlands)

Psychopharmacological treatments in eating disorders & comorbid conditions
Alican Dalkilic (USA)

The place of anorexia nervosa in obsessive compulsive disorders
Atila Erol (Turkey)

Psychiatric assesments and follow ups of obese bariatric surgery patients
Guzin M. Sevincer (Turkey)

HALL B
Joint Symposium-6: TAP - Marce Society
Impact of Maternal Treatments on the Infant During the Perinatal Period

Discussant Moderators:
Nine Glangeaud (France) - Oguz Omay (France)

Impact of psychotropic drug intake during pregnancy on infant outcome: results of the Marcé Francophone MBU's database
Al Sutter-Dallay (France)

What place for substitution treatments in obstetrics and neonatal care
Domnique Dallay (France)

Impact of lithium treatment during pregnancy on infants,
M. Luisa Imaz (Spain)

How to approach bipolar disorder patients who plans pregnancy?
Mine Sahingoz (Turkey)

Ethical considerations, legal responsibilities and key notes on perinatal psychiatric patients in medical therapy
Goksen Yuksel (Turkey)

HALL C
Joint Symposium-7:
Psychiatry and psychopharmacotherapy in Post Soviet space: the bridge between Europe and Asia

Discussant Moderators:
Peter Morozov (Russia) -
Haluk Savas (Turkey)

Introduction
P.Morozov (Russia)

Psychiatric service of Republic of Kazakhstan: tasks and prospects
S.A. Altynbekov (Kazakhstan)

Unappropriate use of antipsychotic drugs, as a one of the problems of emotional burnout
T.I. Galako (Kyrgyzstan)

Correction of astenoadinamic option of postabstinent disorders
Khodjaeva (Uzbekistan)

Experience of Interregional collaboration within educational and scientific projects for Early career psychiatrists
D.A. Smirnova (Russia)

Can pharmaceutical firms support mental health reforms?
Giorgi Geleishvili (Georgia)

18:30-19:00

COFFEE BREAK

19:00-20:30

HALL B
Symposium-7: Antipsychotics Based Weight Gain Due to Hypothalamic Regulation of Eating Disorder, the Main Factor? METU-GATA Sharing the Results of Project Work

Discussant Moderators:
Murad Atmaca (Turkey) - Ozcan Uzun (Turkey)

Regulation of normal eating behavior and METU-GATA information about working with a team of project processes
Mehmet Ak (Turkey)

Atypical antipsychotic induced weight gain associated with disruption of the hypothalamic regulation: METU-GATA results of the study group of patients.
Levent Sutcugil (Turkey)

Atypical antipsychotic induced weight gain factor of hypothalamic neuropeptide gene expression regulatory changes? METU-GATA rat results of the study group
Tulin Yanik (Turkey)

Other possible mechanisms of antipsychotic induced weight gain and preventive treatment options
Suleyman Akarsu (Turkey)

HALL C
Symposium-8
Title: Treatment and Therapeutic Applications in Patients with Schizophrenia

Discussant Moderators:
Erdal Isik ( Turkey)
Orhan Dogan (Turkey)


Cope with depression in schizophrenia,
Erdal Isik (Turkey)

Treatment of patients with schizophrenia collaboration, compliance with treatment,
Orhan Dogan (Turkey)

Rational use of antipsychotics in patients with schizophrenia,
Hulya Turgut (Turkey)

Properties of antipsychotics in schizophrenic patients care centers,
E. Erdal Ersan (Turkey)

Psychiatric rehabilitation in schizophrenia,
Mustafa Yildiz (Turkey)

Course-8
Suicidality in Youth: Risk Factors, Screening, Assessment, and Intervention

Andres J. Pumariega (USA) (English)
Alican Dalkilic (USA) (English)
 Course-9
Fundamentals of Child and Adolescent Psychopharmacology-I

John T. Walkup (USA) (English)
 Course-10
Rehabilitation in Severe Mental Illnesses and Its Role in Operation of Community Mental Health Centers

Hulya Ensari, (Turkey) (Turkish)
Mehtap Arslan (Turkey) (Turkish)

Turkish - English; English-Turkish simultane translation